Pfizer, BioNTech claim their Covid-19 vaccine 90 pc effective in Phase 3 trial

India Today 2020-11-09

Views 534

Pfizer Inc and BioNTech SE on Monday said that their Covid-19 vaccine candidate showed 90 per cent effectiveness in Phase 3 trials
Show more

Share This Video


Download

  
Report form
RELATED VIDEOS
Pfizer-BioNTech COVID-19 Vaccine Phase 3 Clinical Study Results
play
05:53

Pfizer-BioNTech COVID-19 Vaccine Phase 3 Clinical Study Results
Pfizer and BioNTech to start phase 3 COVID-19 vaccine trial
play
03:07

Pfizer and BioNTech to start phase 3 COVID-19 vaccine trial
Pfizer, BioNTech announce Covid-19 vaccine candidate is 90% effective
play
04:00

Pfizer, BioNTech announce Covid-19 vaccine candidate is 90% effective
COVID-19 vaccine is 90 percent effective: Pfizer and BioNTech
play
02:41

COVID-19 vaccine is 90 percent effective: Pfizer and BioNTech
Pfizer says its Covid-19 vaccine 90% effective in Phase 3 trial; Bihar all set for election results tomorrow; more
play
50:34

Pfizer says its Covid-19 vaccine 90% effective in Phase 3 trial; Bihar all set for election results tomorrow; more
Moderna to supply COVID-19 vaccine to Korea in May, WHO grants emergency use approval for Pfizer-BioNTech vaccine
play
00:40

Moderna to supply COVID-19 vaccine to Korea in May, WHO grants emergency use approval for Pfizer-BioNTech vaccine
Pfizer Coronavirus Vaccine: Pfizer ने विकसित केलेली COVID-19 वरची लस 90% परिणामकारक
play
01:47

Pfizer Coronavirus Vaccine: Pfizer ने विकसित केलेली COVID-19 वरची लस 90% परिणामकारक
#SentroBalita | Mass vaccination ng Russia vs COVID-19, sisimulan na sa susunod na linggo; COVID-19 vaccine ng Pfizer and Biontech, may emergency use authorization na mula sa U.K.
play
02:27

#SentroBalita | Mass vaccination ng Russia vs COVID-19, sisimulan na sa susunod na linggo; COVID-19 vaccine ng Pfizer and Biontech, may emergency use authorization na mula sa U.K.
COVID-19 vaccine ng Pfizer BioNTech, 90.7% na epektibo sa pagpigil ng COVID-19 sa mga 5-11 anyos | UB
play
00:50

COVID-19 vaccine ng Pfizer BioNTech, 90.7% na epektibo sa pagpigil ng COVID-19 sa mga 5-11 anyos | UB
Pfizer/BioNTech Says Booster Dose Is 95.6% Effective in Phase 3 Trial
play
01:30

Pfizer/BioNTech Says Booster Dose Is 95.6% Effective in Phase 3 Trial
UK approves Pfizer-BioNTech Covid-19 vaccine for use
play
06:24

UK approves Pfizer-BioNTech Covid-19 vaccine for use
Stony Brook Medicine Receives Pfizer-BioNTech COVID-19 Vaccine
play
03:10

Stony Brook Medicine Receives Pfizer-BioNTech COVID-19 Vaccine